Sociodemographic and Clinical Predictors of Childhood-Onset SLE Disease Activity in the Childhood Arthritis and Rheumatology Research Alliance Registry Emily A. Smitherman, MD – University of Alabama at Birmingham
9:00 AM – 11:00 AM ET
Elucidating Research Priorities in Childhood-Onset Systemic Lupus Erythematosus: A Qualitative Study Laura Cannon, MD – Duke University
9:00 AM – 11:00 AM ET
Development of Autoimmune Diseases and HLA Associations in Children with Neonatal Lupus and Their Unaffected Siblings Amit Saxena, MD – NYU School of Medicine
9:00 AM – 11:00 AM ET
Long-Term Outcomes in Children Born to Anti-Ro and/or Anti-La Positive Mothers Talia Diaz, MD – The Hospital for Sick Children
9:00 AM – 11:00 AM ET
Genetics of Age at Diagnosis in Systemic Lupus Erythematosus Raffaella Carlomagno, MD – The Hospital for Sick Children
9:00 AM – 11:00 AM ET
Low Copy Number of Long C4 Genes Is a Genetic Risk Factor for Childhood Onset SLE (cSLE) but Is Associated with Higher Age of Disease Onset Fatima Barbar-Smiley, MD, MPH – Nationwide Children's Hospital
9:00 AM – 11:00 AM ET
Identifying Rare Genetic Variants in Childhood-onset Monogenic Systemic Lupus Erythematosus Melissa Misztal, -None- – The Hospital for Sick Children
9:00 AM – 11:00 AM ET
Renal Activity Index for Lupus Nephritis Distinguishes Active Renal Disease Among Childhood Systemic Lupus Erythematosus Patients Najla Aljaberi, MBBS – Cincinnati Children's Hospital Medical Center
9:00 AM – 11:00 AM ET
Principles of Pediatric Lupus Nephritis in a Contemporary Multi-Center Cohort Kathleen Vazzana, DO – Children's National Hospital
9:00 AM – 11:00 AM ET
Pediatric and Adolescent One Year Protocol Kidney Biopsies Should Be Performed, Even in Patients with Complete Remission of Their Lupus Nephritis Peter D. Yorgin, MD – UCSD/Rady Children's Hospital
9:00 AM – 11:00 AM ET
Microstructural Damage Is Associated with Age at Disease-onset and Cognitive Impairment in Systemic Lupus Erythematosus Simone Appenzeller, MD, PhD – Unicamp
9:00 AM – 11:00 AM ET
Neuropsychiatric Involvement in Juvenile-onset Systemic Lupus Erythematosus (JSLE): Data from the UK JSLE Cohort Study Teresa Giani, MD – AOU Meyer Children Hospital, Florence
9:00 AM – 11:00 AM ET
Schizophrenia Genetics and Neuropsychiatric Features in Childhood-Onset Systemic Lupus Erythematosus Ana C. Ulloa Baez, MPH – The Hospital for Sick Children
9:00 AM – 11:00 AM ET
Hydroxychloroquine Blood Levels Predicts 6-Months Disease Activity in Juvenile Lupus Nephritis Verena Balbi, MD – Children´s Institute, Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP)
9:00 AM – 11:00 AM ET
Developing a Standardized Corticosteroid Dosing Regimen in Pediatric Proliferative Lupus Nephritis Nathalie E. Chalhoub, MD, MSc – The University of Cincinnati College of Medicine
9:00 AM – 11:00 AM ET
Lupus Anticoagulant as a Predictor of Adverse Outcomes in Children with Venous Thromboembolism Elizabeth Sloan, MD – University of Texas Southwestern Medical Center
9:00 AM – 11:00 AM ET
Hemophagocytic Lymphohistiocytosis (HLH) Gene Variants in Childhood-onset SLE (cSLE) with Macrophage Activation Syndrome (MAS) Piya Lahiry, MD, PhD – N/A
9:00 AM – 11:00 AM ET
Goal-Setting Improves Transition Readiness in Adolescents with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus Teresa Semalulu, MD, MPH – McMaster University
9:00 AM – 11:00 AM ET
Ready or Not? Measuring Readiness for Transition to Adult Care in Adolescents with JIA & jSLE Jeanine McColl, MD – University of Toronto
9:00 AM – 11:00 AM ET
Increase in Emergency Department Visits and Hospitalizations, Decrease in Outpatient Visits Following Transition to Adult Rheumatologic Care Jessica Greco, MD – Ohio State University/Nationwide Children's Hospital
9:00 AM – 11:00 AM ET
Impact of the COVID-19 Pandemic Among Children with Rheumatic Diseases from Around the Globe Jonathan Hausmann, MD – Boston Children's Hospital / Beth Israel Deaconess Medical Center
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Kawasaki Disease Shock Syndrome in the Intensive Care Unit: A Single Center Cohort Monica Bray, MD – Baylor College of Medicine
9:00 AM – 11:00 AM ET
Long-term Hearing Loss, Anxiety and Neurodevelopmental Outcomes Following Kawasaki Disease: A Population-based Cohort Study Cal Robinson, MD – The Hospital for Sick Children
9:00 AM – 11:00 AM ET
Unexpectedly High Incidence of Kawasaki Disease in a Well-Characterized Population in Atlantic Canada Abdulrahman Alkanhal, MBBS, MPH – University of Alberta
9:00 AM – 11:00 AM ET
Henoch-Schönlein Purpura Nephritis: Different Histological Classifications, but Which One Is Most Strongly Associated to the Outcome of the Disease? Pilot Study of the Paediatric Rheumatology European Society Vasculitis Working Party Mario Šestan, MD – University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia
9:00 AM – 11:00 AM ET
Applied Geostatistics in Pediatric Rheumatology – Spatial Clustering of IgA Vasculitis Mario Šestan, MD – University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Evaluation of B-cell Depletion with Rituximab and IVIG Concurrent Treatment in Pediatric Autoimmune Brain Disease Alexis Harmon, BS – Duke University School of Medicine
9:00 AM – 11:00 AM ET
Risk Factors Associated with Pneumocystis Jirovecii Pneumonia in Juvenile Myositis in North America Sara Sabbagh, DO – Medical College of Wisconsin
9:00 AM – 11:00 AM ET
Anti-Melanoma Differentiation Associated Protein 5 (MDA5) Positive Juvenile Dermatomyositis: Focus on the Lung David Moreno McNeill, MD – Baylor College of Medicine/Texas Childrens Hospital
